46 results on '"Alyautdin,Renad"'
Search Results
2. Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems
3. Russian pharmacovigilance: ways to improve efficiency
4. Targeted Delivery Methods for Anticancer Drugs
5. PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs
6. O-BN002. Intravenous administration of poly(lactide-co-glycolide) nanoparticle encapsulating brain-derived neurotrophic factor promotes neuroprotection in an ischemic stroke model in the rat
7. Fullerene–Interfaced Porphyrin Ligand in Affinity Chromatography of Membrane Proteins
8. Elaboration of regulatory approaches to managing the risk of the use of biomedical cell products in the Russian Federation
9. Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles
10. Neuroprotective effect of poly(lactic-co-glycolic acid) nanoparticle-bound brain-derived neurotrophic factor in a permanent middle cerebral artery occlusion model of ischemia in rats
11. Gastroprotective effect of Berberis vulgaris on ethanol-induced gastric mucosal injury: Histopathological evaluations.
12. Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
13. Using Nanoparticles to Target Drugs to the Central Nervous System
14. The Mitochondria Free Iron Content to Limit an Isotope Effect of 25Mg2+ in ATP Synthesis: A caution
15. Nanoscale drug delivery systems and the blood–brain barrier
16. A Brief History of Progress on Nanotechnology: When Will the 'Magic' Nanobullet Shoot?
17. Effects of BDNF-loaded poly (lactide-co-glycolide) nanoparticle on hBMEC cell viability and its effectiveness in penetrating the BBB model
18. Optimization of poloxamer 188 concentration as media for nanoparticle dispersion: effect of concentration, nanoparticle size and in vitro penetration through blood brain barrier
19. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
20. Nanoscale drug delivery systems and the blood–brain barrier
21. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury
22. The development of system of professional information about pharmaceuticals: Quo vadis?
23. A mouse model of weight-drop closed head injury: emphasis on cognitive and neurological deficiency
24. Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness
25. Brain targeting of nerve growth factor using poly(butylcyanoacrylate) nanoparticles
26. The Entrapment of Paclitaxel in PLGA Nanoparticles Increases its Cytotoxicity against Multiresistant Cell Line
27. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes
28. Nanoscale drug delivery systems and the blood–brain barrier
29. Mechanism of the anticataract effect of liposomal magnesium taurate in galactose-fed rats.
30. Liposomes in topical ophthalmic drug delivery: an update
31. Ocular Tissue Distribution of Topically Applied PEGylated and Non-PEGylated Liposomes
32. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
33. Liposomes in topical ophthalmic drug delivery: an update.
34. The Mitochondria Free Iron Content to Limit an Isotope Effect of 25Mg2+ in ATP Synthesis: A caution
35. The tissue-specific “ferromagnetic attack” on hyperactivation of ATP synthesis by magnesium-25 in mitochondria
36. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
37. Fullerene-based Low Toxic Nanocationite Particles (Porphyrin Adducts of Cyclohexyl Fullerene-C60) to Treat Hypoxia-induced Mitochondrial Dysfunction in Mammalian Heart Muscle
38. NEW PORPHYRIN ADDUCT OF FULLERENE-C60: A PROMISING NANOTOOL FOR MEDICINAL USE IN THE HEART MUSCLE HYPOXIA CASES
39. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier
40. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
41. Fullerene-based Low Toxic Nanocationite Particles (Porphyrin Adducts of Cyclohexyl Fullerene-C60) to Treat Hypoxia-induced Mitochondrial Dysfunction in Mammalian Heart Muscle
42. NEW PORPHYRIN ADDUCT OF FULLERENE-C60:: A PROMISING NANOTOOL FOR MEDICINAL USE IN THE HEART MUSCLE HYPOXIA CASES.
43. Calcium and magnesium level in cataractous lenses of galactosemic rats topically treated with liposomal formulation of magnesium taurate
44. Mechanism of the anticataract effect of liposomal magnesium taurate in galactose-fed rats
45. Mechanism of the anticataract effect of liposomal MgT in galactose-fed rats.
46. Effects of topically applied tocotrienol on cataractogenesis and lens redox status in galactosemic rats.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.